ExoVasc® PEARS

Royal Brompton Hospital approves device

Share:

Following the completion of the initial clinical trial the Clinical Practice Committee at the Royal Brompton Hospital has approved the device for use in the treatment of suitable patients with a dilated aorta due to Marfan syndrome

Share:

Related articles

SME News, Managing Director of the Year Awards

Victoria Sharpe named as one of the Top 50 Women in Engineering 2024

Interested in our patient experiences?